Privia Health Group Stock Performance
| PRVA Stock | USD 19.61 1.10 5.31% |
The company holds a Beta of 1.23, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Privia Health will likely underperform. At this point, Privia Health Group has a negative expected return of -0.21%. Please make sure to check Privia Health's kurtosis, and the relationship between the maximum drawdown and day median price , to decide if Privia Health Group performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Privia Health Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in August 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Begin Period Cash Flow | 389.5 M | |
| Total Cashflows From Investing Activities | -12 M |
Privia Health Relative Risk vs. Return Landscape
If you would invest 2,271 in Privia Health Group on April 21, 2025 and sell it today you would lose (310.00) from holding Privia Health Group or give up 13.65% of portfolio value over 90 days. Privia Health Group is currently does not generate positive expected returns and assumes 2.0031% risk (volatility on return distribution) over the 90 days horizon. In different words, 17% of stocks are less volatile than Privia, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Privia Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Privia Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Privia Health Group, and traders can use it to determine the average amount a Privia Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1064
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PRVA |
Estimated Market Risk
| 2.0 actual daily | 17 83% of assets are more volatile |
Expected Return
| -0.21 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Privia Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Privia Health by adding Privia Health to a well-diversified portfolio.
Privia Health Fundamentals Growth
Privia Stock prices reflect investors' perceptions of the future prospects and financial health of Privia Health, and Privia Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Privia Stock performance.
| Return On Equity | 0.0301 | ||||
| Return On Asset | 0.0121 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 2.05 B | ||||
| Shares Outstanding | 121.92 M | ||||
| Price To Book | 3.82 X | ||||
| Price To Sales | 1.33 X | ||||
| Revenue | 1.74 B | ||||
| EBITDA | 24.25 M | ||||
| Cash And Equivalents | 316.9 M | ||||
| Cash Per Share | 2.77 X | ||||
| Total Debt | 5.59 M | ||||
| Debt To Equity | 0.02 % | ||||
| Book Value Per Share | 5.43 X | ||||
| Cash Flow From Operations | 109.28 M | ||||
| Earnings Per Share | 0.12 X | ||||
| Total Asset | 1.14 B | ||||
| Retained Earnings | (179.23 M) | ||||
About Privia Health Performance
By analyzing Privia Health's fundamental ratios, stakeholders can gain valuable insights into Privia Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Privia Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Privia Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC. Privia Health operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 810 people.Things to note about Privia Health Group performance evaluation
Checking the ongoing alerts about Privia Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Privia Health Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Privia Health Group generated a negative expected return over the last 90 days | |
| Over 93.0% of the company shares are owned by institutional investors | |
| Latest headline from gurufocus.com: MARAVAI ALERT Bragar Eagel Squire, P.C. ... |
- Analyzing Privia Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Privia Health's stock is overvalued or undervalued compared to its peers.
- Examining Privia Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Privia Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Privia Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Privia Health's stock. These opinions can provide insight into Privia Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Privia Stock analysis
When running Privia Health's price analysis, check to measure Privia Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Privia Health is operating at the current time. Most of Privia Health's value examination focuses on studying past and present price action to predict the probability of Privia Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Privia Health's price. Additionally, you may evaluate how the addition of Privia Health to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |